FDA Releases Draft Guidance on NAC Enforcement

On April 21, 2022 FDA announced the issuance of draft guidance on FDA’s policy regarding dietary supplements containing N-acetyl cysteine (NAC). The guidance details the agency’s intent to exercise enforcement discretion on the sale and distribution of such products. In 2020 FDA sent warning letters to several companies regarding the use of NAC in dietary... Continue Reading